Paskoy has advised Novartis on the sale of one of Sandoz Turkey’s manufacturing facilities to Turkish pharmaceutical company Generica Ilac.
The transaction includes the transfer of all associated assets and employees of Sandoz Turkey at the facility in Gebze, Turkey. The deal is expected to close by mid-2020 subject to the approval of regulatory authorities, including Turkey's Competition Board, the Gebze Plastic Manufacturers Organized Industrial Zone, and the Ministry of Industry and Technology. After closing, Generica Ilac will continue to manufacture and supply certain products to Novartis.
Paksoy's team included Partner Elvan Aziz, Counsel Nazli Bezirci and Associate Gozde Zorlu.
Paskoy did not reply to our inquiry on the matter.
